GlaxoSmithKline, which previously announced it would suspend the practice of paying outside doctors to promote drugs, has announced that it will instead hire doctors to “educate” their peers about its drugs, though they will not be able to answer questions about treating specific patients. Because they will be Glaxo employees, the company will not have to report payments to the doctors.
Of further interest:
In latest marketing-reform move, GSK recruits in-house doctors to speak for products (Fierce Pharma)
